Literature DB >> 521251

The newer insulins.

J G Devlin, O Maguire, V Parameswaran.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 521251     DOI: 10.1007/BF02938141

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  16 in total

1.  The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.

Authors:  O O Anderson
Journal:  Acta Endocrinol (Copenh)       Date:  1975-04

2.  RELATIONSHIP BETWEEN DIFFERENTIAL ANTIBODY BINDING CAPACITY AND CLINICAL REQUIREMENTS OF BEEF AND PORT INSULIN.

Authors:  J G DEVLIN; T G BRIEN
Journal:  Metabolism       Date:  1965-09       Impact factor: 8.694

3.  Clinical aspects of insulin--antigenicity.

Authors:  J Schlichtkrull; J Brange; A H Christiansen; O Hallund; L G Heding; K H Jorgensen
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

4.  Antibody studies in patients on mixed bovine-porcine insulins.

Authors:  J G Devlin; M Duggan
Journal:  Diabetologia       Date:  1969-06       Impact factor: 10.122

5.  Characterisation of antibody response to monocomponent insulin.

Authors:  J G Devlin; V Parameswaran
Journal:  Ir Med J       Date:  1978-05-26

6.  Highly purified insulins.

Authors:  K G Alberti; M Nattrass
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

7.  Insulin immunology: humoral and cellular aspects in mono-component insulin treated patients.

Authors:  J G Devlin; O Maguire; V Parameswaran; P J Blake
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

8.  Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.

Authors:  C Eff; O Faber; T Deckert
Journal:  Diabetologia       Date:  1978-09       Impact factor: 10.122

9.  beta-cell function in children with diabetes.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

10.  Insulin therapy in relation to circulating C-peptide levels.

Authors:  W Beischer; W Kerner; S Raptis; L Keller; B Beischer; E F Pfeiffer
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.